Ligand Pharmaceuticals Incorporated Intellectual Property Contracts & Agreements

39 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sublicense Agreement between Ligand Pharmaceuticals Incorporated, Pharmacopeia, Inc., and Retrophin, LLC (February 16, 2012)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2022
Commercial License Agreement between Taurus Biosciences, LLC and Minotaur Therapeutics, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2020
Sublicense Agreement between Ligand Pharmaceuticals Incorporated, Pharmacopeia, Inc., and Retrophin, LLC (February 16, 2012)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2020
Addendum to License Agreement between Ligand Pharmaceuticals, CyDex Pharmaceuticals, and Acrotech Biopharma
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2019
License Agreement between Ligand Pharmaceuticals Incorporated and Roivant Sciences GmbH (LGD-6972)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Amendment No. 5 to Sublicense Agreement between Ligand Pharmaceuticals Incorporated, Pharmacopeia, LLC, and Retrophin, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Amendment No. 4 to Sublicense Agreement between Ligand Pharmaceuticals Incorporated, Pharmacopeia, LLC, and Retrophin, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2015
Second Amendment to Master License Agreement among Metabasis Therapeutics, Ligand Pharmaceuticals, and Viking Therapeutics
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2015
First Amendment to Master License Agreement among Metabasis Therapeutics, Ligand Pharmaceuticals, and Viking Therapeutics
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2014
License Agreement between Ligand Pharmaceuticals Incorporated and TG Therapeutics, Inc. (June 23, 2014)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2014
Research and License Agreement between Ligand Pharmaceuticals Incorporated and Omthera Pharmaceuticals, Inc. dated May 9, 2014
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2014
Master License Agreement between Ligand Pharmaceuticals, Metabasis Therapeutics, and Viking Therapeutics (May 21, 2014)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2014
License Agreement Between CyDex Pharmaceuticals, Inc. and Curx Pharmaceuticals, Inc. for Captisol Technology
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
MN
2013
Exclusive License and Distribution Agreement between Ligand Pharmaceuticals Incorporated and Ethicor Pharmaceuticals Ltd.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2013
License Agreement between Ligand Pharmaceuticals Incorporated and Azure Biotech, Inc. (Lasofoxifene)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2013
License Agreement Between CyDex Pharmaceuticals, Inc. and Spectrum Pharmaceuticals, Inc. for Captisol® Technology
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2013
Amended and Restated License Agreement between Ligand Pharmaceuticals Incorporated and Chiva Pharmaceuticals, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2013
Research License and Option Agreement between Ligand Pharmaceuticals Incorporated and Ares Trading SA (Merck) dated April 27, 2012
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2012
Sublicense Agreement between Ligand Pharmaceuticals Incorporated, Pharmacopeia, Inc., and Retrophin, LLC
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2012
License and Supply Agreement between CyDex Pharmaceuticals, Inc. and Hospira, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2012
License Agreement between CyDex Pharmaceuticals, Inc. and Eli Lilly and Company (Captisol® Drug Formulation System)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2012
First Amendment to License Agreement between Ligand Pharmaceuticals Incorporated and Chiva Pharmaceuticals, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2011
License Agreement between ARE-3535/3565 General Atomics Court, LLC and Ligand Pharmaceuticals, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
License Agreement between CyDex Pharmaceuticals, Inc. and The Medicines Company for Captisol® Technology
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NJ
2011
License Agreement between Ligand Pharmaceuticals Incorporated and Chiva Pharmaceuticals, Inc. (Pradefovir, MB07133, and HepDirect Technology)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2011
Amendment to License Agreement between CyDex, Inc. and Prism Pharmaceuticals, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
License Agreement between CyDex, Inc. and Prism Pharmaceuticals, Inc. for Captisol-enabled Amiodarone
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2011
Addendum to Nonexclusive License Agreement between Pfizer Inc. and CyDex, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
Nonexclusive License Agreement between Pfizer Inc. and University of Kansas (June 4, 1996)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
KS
2011
Exclusive License Agreement between Pfizer Inc. and University of Kansas (June 4, 1996)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
KS
2011
Second Amendment to License Agreement between The University of Kansas and CyDex, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
First Amendment to License Agreement between CyDex, Inc. and University of Kansas
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
License Agreement between The University of Kansas and CyDex L.C. for Patent Rights to KUCD and Assignment of Pfizer Licenses
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
KS
2011
Amendment Number One to Research and License Agreement between Trevena, Inc. and Ligand Pharmaceuticals Incorporated
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2010
Exclusive Patent License Agreement between Glycomed, Inc. and ParinGenix, Inc.
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2009
Research and License Agreement between Trevena, Inc. and Ligand Pharmaceuticals, Inc. dated February 5, 2009
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NJ
2009
Exclusive License Agreement between Ligand Pharmaceuticals Incorporated and SmithKline Beecham Corporation (GlaxoSmithKline) for LGD-4665 and Related Compounds
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Amended and Restated Research, Development and License Agreement between Wyeth and Ligand Pharmaceuticals Incorporated (December 1, 2005)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2006
Research, Development and License Agreement between Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated (May 19, 2000)
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2000